Please login to the form below

Not currently logged in
Email:
Password:

Evox Therapeutics

This page shows the latest Evox Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Duchenne UK backs Evox dystrophin delivery project

Duchenne UK backs Evox dystrophin delivery project

Funding will drive preclinical studies on dystrophin-bearing exosomes. Oxford University spin-out Evox Therapeutics has won a £656, 000 ($858, 000) grant from a UK medical charity to test its ... Evox spun out of Oxford University in 2016 with £10m in

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Robert Freisen joins Ablynx Robert Freisen joins Ablynx

    He succeeds Dr Antonin de Fougerolles, who left the company last year to become Evox Therapeutics’ chief executive officer. ... He has previously held roles for ProQR Therapeutics, Janssen BioTherapeutics, and MorphoSys.

  • Tony de Fougerolles joins Evox Therapeutics as CEO Tony de Fougerolles joins Evox Therapeutics as CEO

    Oxford, UK-based Evox Therapeutics has appointed its new chief executive officer in the form of Tony de Fougerolles. ... Dr Lundin said: “After a thorough selection process, I am incredibly pleased that Tony is joining the team as we continue to

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics